Cubist Systematic Strategies’s Corcept Therapeutics CORT Stock Holding History

Cubist Systematic Strategies’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-351,374	Closed	-$8.85M	–	3219
2024 Q1	$8.85M	Buy	351,374 +118,690	+51%	+$2.8M	0.1%	596
2023 Q4	$7.56M	Sell	232,684 -55,494	-19%	-$1.52M	0.09%	613
2023 Q3	$7.85M	Buy	288,178 +188,189	+188%	+$5.45M	0.1%	500
2023 Q2	$2.22M	Sell	99,989 -4,037	-4%	-$92.9K	0.02%	1409
2023 Q1	$2.25M	Sell	104,026 -159,472	-61%	-$3.5M	0.02%	1578
2022 Q4	$5.35M	Buy	263,498 +142,044	+117%	+$3.56M	0.05%	956
2022 Q3	$3.11M	Sell	121,454 -53,419	-31%	-$1.43M	0.02%	1554
2022 Q2	$4.16M	Sell	174,873 -131,139	-43%	-$2.86M	0.03%	1159
2022 Q1	$6.89M	Buy	306,012 +154,184	+102%	+$3.28M	0.06%	505
2021 Q4	$3.01M	Buy	151,828 +96,570	+175%	+$1.96M	0.03%	1019
2021 Q3	$1.09M	Buy	55,258 +29,111	+111%	+$609K	0.01%	1455
2021 Q2	$575K	Buy	26,147 +17,718	+210%	+$394K	0.01%	1915
2021 Q1	$201K	Sell	8,429 -810	-9%	-$21.6K	﹤0.01%	2473
2020 Q4	$242K	Sell	9,239 -21,196	-70%	-$447K	﹤0.01%	2141
2020 Q3	$530K	Sell	30,435 -92,293	-75%	-$1.47M	0.01%	1710
2020 Q2	$2.06M	Buy	122,728 +35,085	+40%	+$493K	0.04%	775
2020 Q1	$1.04M	Sell	87,643 -13,780	-14%	-$171K	0.03%	806
2019 Q4	$1.23M	Buy	101,423 +3,847	+4%	+$53.6K	0.02%	1033
2019 Q3	$1.38M	Buy	97,576 +71,429	+273%	+$878K	0.03%	813
2019 Q2	$292K	Sell	26,147 -25,851	-50%	-$288K	0.01%	1822
2019 Q1	$610K	Buy	51,998 +15,619	+43%	+$194K	0.02%	1059
2018 Q4	$486K	Buy	+36,379	New	+$481K	0.02%	992
2018 Q1	–	Sell	-15,714	Closed	-$284K	–	1868
2017 Q4	$284K	Sell	15,714 -9,366	-37%	-$170K	0.02%	1285
2017 Q3	$484K	Sell	25,080 -9,517	-28%	-$142K	0.03%	846
2017 Q2	$408K	Sell	34,597 -10,623	-23%	-$115K	0.03%	850
2017 Q1	$496K	Sell	45,220 -25,663	-36%	-$225K	0.04%	643
2016 Q4	$515K	Buy	+70,883	New	+$555K	0.04%	653
2015 Q4	–	Sell	-10,311	Closed	-$39K	–	1777
2015 Q3	$39K	Buy	+10,311	New	+$52.3K	﹤0.01%	1742